Press Releases

SAN DIEGO, March 23, 2020 /PRNewswire/ -- Prometheus Biosciences, Inc. ("Prometheus"), a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases, announced today that it has launched the Mo

HOUSTON, March 23, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced the results from its pivotal cellulite t

HOUSTON, March 23, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company primarily specializing in the development of novel treatments for cancers of the brain and central nervous system, announces it has entered into an agreement with WPD Pharmaceuticals Inc. (CSE: WBIO) for the development of se

NORTH CHICAGO, Ill., March 23, 2020 /PRNewswire/ -- AbbVie Inc. (NYSE:ABBV) ("AbbVie") announced today the extension of the expiration date of the offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes of certain series issued by Allergan Finance, LLC ("Allergan Finance"), Allergan, Inc. ("Allergan Inc"

NORTH CHICAGO, Ill., March 23, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the VIALE-A (M15-656) trial of VENCLEXTA® (venetoclax) in combination with azacitidine versus azacitidine in combination with placebo met its dual primary endpoints of statistically significant improvement

SAN FRANCISCO, March 23, 2020 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company today announced its partnership with the Muscular Dystrophy Association (MDA)  to off

CRANBURY, N.J., March 23, 2020 /PRNewswire/ -- With the emergence of COVID-19 (novel coronavirus) has come tremendous global concern and uncertainty. In response, the Academy of Oncology Nurse & Patient Navigators (

NEW HAVEN, Conn., March 23, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or, the "Company") today announced a successful end of Phase 2 clinical and nonclinical interaction with the U.S. Food and Drug Administration (FDA) for intranasal vazegepant for the acute treatment of migraine. The Company addressed all issues rai

ATLANTA, March 23, 2020 /PRNewswire/ -- Aaron's, Inc. (NYSE: AAN), a leading omnichannel provider of lease-purchase solutions, today announced business updates in connection with the continued spread of COVID-19.

PALO ALTO, Calif., March 23, 2020 /PRNewswire/ -- As people deal with illness and quarantines, new polling from LeanIn.Org shows that three-quarters of Americans (76%) support expanding paid sick leave access beyond the provisions included in the